A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children

CG Grijalva, SI Pelton - Current opinion in pediatrics, 2011 - journals.lww.com
This article reviews the lessons learned from a decade of experience with PCV7, the
increasing problem of disease due to nonvaccine serotypes, and the likelihood of PCV13 to …
被引用次数：43 相关文章

A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children.

CG Grijalva, SI Pelton - Current Opinion in Pediatrics, 2011 - europepmc.org
This article reviews the lessons learned from a decade of experience with PCV7, the
increasing problem of disease due to nonvaccine serotypes, and the likelihood of PCV13 to …

[引用][C] A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children

CG Grijalva, SI Pelton - Current Opinion in Pediatrics, 2011 - cir.nii.ac.jp
A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal
diseases in children | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

A Second Generation Pneumococcal Conjugate Vaccine for Prevention of Pneumococcal Diseases in Children

CG Grijalva, SI Pelton - Current Opinion in Pediatrics, 2011 - stacks.cdc.gov
Purpose A second generation 13 valent pneumococcal conjugate vaccine (PCV13) was
licensed and recommended for universal immunization of children through age five years in …

A second-generation pneumococcal conjugate vaccine for prevention of pneumococcal diseases in children

CG Grijalva, SI Pelton - Current opinion in pediatrics, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose of review A second-generation 13-valent pneumococcal conjugate vaccine
(PCV13) was licensed and recommended for universal immunization of children through …
[HTML] nih.gov

[HTML][HTML] A Second Generation Pneumococcal Conjugate Vaccine for Prevention of Pneumococcal Diseases in Children

CG Grijalva, SI Pelton - Current Opinion in Pediatrics, 2011 - ncbi.nlm.nih.gov
Purpose A second generation 13 valent pneumococcal conjugate vaccine (PCV13) was
licensed and recommended for universal immunization of children through age five years in …
[PDF] cdc.gov

[PDF][PDF] A Second Generation Pneumococcal Conjugate Vaccine for Prevention of Pneumococcal Diseases in Children

CG Grijalva, SI Pelton - Curr Opin Pediatr, 2011 - stacks.cdc.gov
Purpose—A second generation 13 valent pneumococcal conjugate vaccine (PCV13) was
licensed and recommended for universal immunization of children through age five years in …